CClinicalTrials.gg
CompletedNCT06962514BFRTUpdated Jul 31, 2025

Low Load With Blood Flow Restriction for Improving Strength, Balance, and Cognition in Older Adults

An interventional study of Blood flow restriction cuff and Exercise without BFR cuff in Blood Flow Restriction Exercise, Resistance Training and Elderly (People Aged 65 or More), sponsored by Sahmyook University. Completed at 1 site in South Korea. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-07-31.

Sponsored by Sahmyook University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

This study aims to examine the effects of low load resistance exercise with a blood flow restriction cuff on muscle strength, balance, physical performance, depression, and cognitive function in community-dwelling older adults.

Read the detailed description

This randomized controlled trial investigates the effects of low-load resistance exercise combined with blood flow restriction (BFR) in community-dwelling older adults. A total of 26 participants aged 65 and older will be randomly assigned to either a BFR exercise group or a control group that performs the same resistance exercises without BFR.

The intervention will be conducted twice a week for 8 weeks (16 sessions total). The BFR cuffs will be applied at 50% of the participant's arterial occlusion pressure. Both groups will undergo the same exercise protocol, supervised by trained personnel. Assessments will be performed at baseline and after the intervention.

Primary outcome measures include lower limb strength (5 Times Sit-to-Stand Test), balance ability (Timed Up and Go test), gait performance (10-meter walk test, GaitRite), muscle mass index (SMI) using BWA 2.0, muscle thickness (quadriceps via ultrasound), cognitive function (MoCA), depression level (GDS-K).

Both participants and outcome assessors are blinded to group allocation. This study has received IRB approval from Sahmyook University Institutional Review Board.

02

Conditions studied

  • Blood Flow Restriction Exercise
  • Resistance Training
  • Elderly (People Aged 65 or More)
  • Muscle Strength
  • Balance
  • Cognition
  • Depression

Browse trials for

Keywords

  • Blood flow restriction training
  • Older adults
  • Muscle mass
  • Functional Mobility
  • Cognition
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 26 is below the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Sahmyook University is the lead sponsor of 42 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Community-dwelling individuals aged 65 years and older who have not had a fall in the past year.
  2. No neurological or musculoskeletal condition that would interfere with exercise performance.
  3. Clear consciousness and able to communicate effectively.
  4. Capable of reading and writing.
  5. Able to understand the research explanation and provide informed consent.

Exclusion criteria

Exclusion Criteria:

  1. Orthopedic, neurological, or vascular conditions that may affect vital signs such as dizziness, blood pressure instability, or fall risk during assessment.
  2. Any history of musculoskeletal surgery within the past 6 months.
  3. Physician-determined health status that contraindicates exercise participation.
  4. Cognitive or literacy impairments that hinder understanding of study procedures.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    BFR group

    Exercise with BFR cuff

    Other: Blood flow restriction cuff

  • Experimental
    Exercise group

    Exercise without BFR cuff

    Other: Exercise without BFR cuff

Interventions

  • OtherBlood flow restriction cuff

    Use of blood flow restriction cuff during resistance training. The cuff pressure is set at 50% of the participant's arterial occlusion pressure.

  • OtherExercise without BFR cuff

    Resistance exercise performed without blood flow restriction. Same protocol as BFR group but without cuff application.

06

What researchers measure

Primary outcomes

  1. Quadriceps muscle thickness (via ultrasound)

    Muscle thickness of the rectus femoris and vastus intermedius will be assessed using B-mode ultrasound at rest. Measurements will be taken pre- and post-intervention.

    Time frame: From baseline to the end of the 8-week intervention.

  2. Skeletal Muscle Mass Index (SMI)

    SMI will be calculated using appendicular lean mass obtained from bioelectrical impedance analysis (BWA 2.0) and height squared (kg/m²). Handgrip strength will also be assessed as an indicator of muscle function.

    Time frame: From baseline to the end of the 8-week intervention.

Secondary outcomes

  1. Lower limb strength (5 Times Sit to Stand Test)

    Lower extremity strength will be assessed using the Five Times Sit to Stand Test, measuring the time required to stand from a chair and sit down five times.

    Time frame: From baseline to the end of the 8-week intervention.

  2. Depression level (GDS-K)

    Depressive symptoms will be assessed using the Korean version of the Geriatric Depression Scale (GDS-K), a standardized self-report screening tool for older adults. It consists of 30 items, each answered with "Yes" or "No." The total score ranges from 0 to 30, with higher scores indicating more severe depressive symptoms. Scores are interpreted as follows: 0-13 = normal, 14-18 = mild depression, 19-21 = moderate depression, and 22 or above = severe depression.

    Time frame: From baseline to the end of the 8-week intervention.

  3. Cognitive function (MoCA)

    Cognitive function will be evaluated using the Korean version of the Montreal Cognitive Assessment (MoCA-K), a validated screening tool for mild cognitive impairment in older adults. It assesses multiple cognitive domains, including attention, memory, language, visuospatial skills, executive functions, and orientation. The total score ranges from 0 to 30, with higher scores indicating better cognitive performance. A score below 23 is generally considered indicative of cognitive impairment. One point may be added for individuals with 6 or fewer years of formal education.

    Time frame: From baseline to the end of the 8-week intervention.

  4. Gait performance (10-meter walk test and Gaitrite)

    Gait speed and spatiotemporal gait parameters will be measured using a 10-meter walk test and GaitRite system at comfortable walking speed.

    Time frame: From baseline to the end of the 8-week intervention.

  5. Balance ability (TUG)

    Dynamic balance will be assessed using the Timed Up and Go (TUG) test.

    Time frame: From baseline to the end of the 8-week intervention.

07

Study locations

1 site
  • Sahmyook University, Graduate School of Physical Therapy
    Seoul, 01795, South Korea
08

References and documents

Individual participant data

Plan to share: Undecided — The decision to share individual participant data (IPD) has not been finalized. The data may be considered for sharing after de-identification and upon request, depending on future publication requirements and institutional policy.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06962514
Lead sponsor
Sahmyook University
Responsible party
Hongje Jang (Physical Therapist, Sahmyook University) — Principal investigator
First posted
May 8, 2025
Start date
May 12, 2025
Primary completion
Jul 10, 2025
Completion
Jul 14, 2025
Last update
Jul 31, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion